Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Honghua Xiaoyao is a Traditional Chinese Medicine (TCM) botanical formulation used for the treatment of gynecological disorders, specifically premenstrual syndrome (PMS) and menstrual irregularities. It is a derivative of the classic Xiaoyao San formula, enriched with *Carthamus tinctorius* (Honghua) to enhance its blood-circulating and stasis-resolving properties. The formulation typically includes herbs such as *Angelica sinensis*, *Paeonia lactiflora*, and *Bupleurum chinense*. It is primarily indicated for Liver Qi stagnation and Blood deficiency in TCM diagnostics, which clinically manifests as emotional instability, breast tenderness, and abdominal pain associated with the menstrual cycle. Recent clinical research has utilized target trial emulation (TTE) frameworks to evaluate its real-world efficacy and safety compared to standard interventions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on honghua xiaoyao.